CClinicalTrials.gg
CompletedNCT04042467Updated Sep 29, 2026Results posted

Greenlight Plus Study: Approaches to Early Childhood Obesity Prevention

An interventional study of Greenlight Plus and Greenlight in Behavior, Health and Child Obesity, sponsored by Vanderbilt University Medical Center. Completed at 6 sites in United States. Open to participants aged Up to 21 Days, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by Vanderbilt University Medical Center · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
900
Allocation
Randomized
Ages
Up to 21 Days
Sex
All
01

Study summary

A randomized controlled trial enrolling 900 parent-infant dyads (English and Spanish speaking) comparing Greenlight (control), a behavioral intervention focusing on nutrition, physical activity, media use, and sleep as compared to Greenlight Plus (intervention) which includes the above materials plus a health information technology (HIT) intervention aimed at supporting family goal-setting and behavior change during well-child checks throughout the first 2 years of life.

Read the detailed description

The investigators propose a randomized trial to compare the effectiveness of two different approaches to early childhood obesity prevention in children 0-2 years of age. The investigators will randomize 900 parent-infant dyads, recruited from six newborn nurseries/primary care clinics. The participating organizations are part of both CORNET, a national practice-based research network of pediatric residency primary care practices supported by the Academic Pediatric Association (APA), and PCORnet, the national research network supported by PCORI. In the nursery or at the first newborn clinic visit, eligible families will be consented and randomized to one of two arms. In Arm 1 ("Greenlight"), during each of the recommended well child visits from 0-24 months, pediatric residents, trained in clear health communication skills and shared goal-setting, will use the Greenlight Toolkit of low literacy, age-specific, parent education booklets to promote healthy family behaviors and obesity prevention. In Arm 2 ("Greenlight Plus"), families will receive the Greenlight intervention plus a health information technology (HIT) intervention aimed at supporting family goal-setting and behavior change. This design allows us to determine if HIT and the asynchronous support it provides between well-child visits can promote additional behavior change and obesity prevention.

Specific Aims \& Hypotheses (H) include:

Aim 1: Compare the effectiveness of the 2 arms on weight-for-length and other weight measures through age 2.

H1: Arm 2 will be significantly better than Arm 1 in supporting healthy child weight-for-length trajectory over 2 years;

Aim 2: Compare the effectiveness of the two approaches on parent-reported outcomes, including child feeding and physical activity behaviors, parent feeding beliefs and behaviors, media use, and quality of doctor-patient communication.

H2: Arm 2 will be significantly better at improving parent-reported health behaviors.

Aim 3: Examine differences in main outcomes by social determinants, including race/ethnicity, language, health literacy.

H3: A literacy- and culturally-sensitive approach to obesity prevention will result in equal subgroup improvements.

Aim 4: To compare weight-for-length trajectory over 2 years in both intervention arms with a non-enrolled comparison group, using data from the PCORnet Common Data Model at participating sites.

H4: PCORnet analysis will reveal the benefit of both Greenlight approaches (Arms 1 and 2) compared to before Greenlight intervention implementation and the added benefit of Arm 2 (Greenlight Plus) over other approaches.

02

Conditions studied

  • Behavior, Health
  • Child Obesity
03

In context

Health Behavior

228 studies on the registry are indexed under Health Behavior; 95 are open to participants now.

This study's enrollment of 900 is above the median of 114 across 196 interventional studies indexed under Health Behavior.

Browse Health Behavior studies →

Lead sponsor

Vanderbilt University Medical Center is the lead sponsor of 824 studies on the registry; 164 are open to participants now.

Of its 122 completed or terminated interventional studies of FDA-regulated products, 91 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 21 Days
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

For this study, eligible caregiver/infant dyads will be those with:

  1. an English- or Spanish-speaking parent/legal guardian,
  2. infant born in the newborn nursery with plans to have care in the local clinic OR presenting in that clinic for the first newborn visit (1-21 days of life),
  3. attendance at first newborn clinic visit
  4. no plans to leave the clinic within 2 years
  5. Completion of baseline data collection (survey data, child weight and length measures prior to randomization).
  6. Own a smartphone with access to data services

Exclusion criteria

Exclusion Criteria:

Infant exclusion criteria:

  1. born prior to 34 weeks gestation or birth weight \<1500 grams; weight \<3rd %tile at enrollment (World Health Organization growth curves); or
  2. any chronic medical problem that may affect weight gain (e.g., metabolic disease, uncorrected congenital heart disease, renal disease, high-calorie formula; cleft palate; Down syndrome).

Caregiver exclusion criteria include:

  1. \<18 years old;
  2. serious mental or neurologic illness that impairs ability to consent/participate;
  3. poor visual acuity (corrected vision worse than 20/50 with Rosenbaum Screener).
  4. biological mother is HIV-positive
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
900 participants (actual)

Study arms

  • Experimental
    Greenlight Plus

    Families will receive the Greenlight intervention plus a health information technology (HIT) intervention aimed at supporting family goal-setting and behavior change. This design allows us to determine if HIT and the asynchronous support it provides between well-child visits can promote additional behavior change and obesity prevention.

    Behavioral: Greenlight Plus · Behavioral: Greenlight

  • Active comparator
    Greenlight

    During each of the recommended well child visits from 0-24 months, pediatric residents, trained in clear health communication skills and shared goal-setting, will use the Greenlight Toolkit of low literacy, age- specific, parent education booklets to promote healthy family behaviors and obesity prevention.

    Behavioral: Greenlight

Interventions

  • BehavioralGreenlight Plus

    Families randomized to the Greenlight Plus arm will receive a HIT intervention starting at the newborn clinic visit. During the newborn visit, these families will receive basic instructions on how to access the Greenlight technology platform, which includes the iOTA text-messaging application and a website (usable on desktop or mobile platform). Families will receive text messages and goal-setting over the first 2 years of the child's life.

  • BehavioralGreenlight

    All residents and families seen in the participating clinics will receive the basic Greenlight materials.

06

What researchers measure

Primary outcomes

  1. Child Weight for Length Trajectory

    The primary outcome was child weight for length (kg/m) trajectory over 2 years. Weight and length measurements were obtained during pediatric care visits and abstracted from the medical record.

    Time frame: Baseline to 24 months

Secondary outcomes

  1. Child BMI Z-score Trajectory

    Time frame: Baseline to 24 months

  2. Child Weight-for-length Z-score Trajectory

    Time frame: Baseline to 24 months

  3. Child Overweight and/or Obesity

    Outcome defined by CDC or WHO standards

    Time frame: at 24 months

07

Results

Posted Oct 16, 2025
Limitations and caveats
Some population groups were underrepresented or not represented (e.g., patients who did not prefer to speak English or Spanish). The study was unable to collect reliable data on web-based dashboard use, limiting the ability to evaluate which digital components of the Greenlight Plus intervention were associated with effectiveness. Anthropometric measures collected during clinical care may be susceptible to measurement error. However, annual training was implemented to minimize errors.

Participant flow

Participants were recruited from medical clinics at six medical centers: Duke University, University of Miami, New York University Grossman School of Medicine/Bellevue Hospital Center, University of North Carolina at Chapel Hill, Stanford University, and Vanderbilt University Medical Center. Study enrollment occurred between November 2019 and August 2021.

Participant flow — Overall Study
MilestoneGreenlight PlusGreenlight
Started449451
Completed385392
Not completed6459

Outcome measures

PrimaryChild Weight for Length Trajectory

The primary outcome was child weight for length (kg/m) trajectory over 2 years. Weight and length measurements were obtained during pediatric care visits and abstracted from the medical record.

Time frame:
Baseline to 24 months
Reported as:
Mean · kg/m
Child Weight for Length Trajectory
kg/mGreenlight PlusGreenlight
1 Month8.0 ± 0.98.0 ± 0.8
2 Months9.3 ± 1.09.4 ± 1.0
4 Months10.8 ± 1.211.0 ± 1.2
6 Months11.9 ± 1.212.0 ± 1.3
9 Months12.7 ± 1.312.9 ± 1.3
12 Months13.1 ± 1.313.4 ± 1.5
15 Months13.5 ± 1.413.8 ± 1.6
18 Months13.9 ± 1.414.2 ± 1.6
24 Months14.8 ± 1.615.2 ± 2.0
Statistical analysis
  • Greenlight Plus vs Greenlight · Regression, Linear · p = <0.001 (The p-value was not adjusted for multiple comparisons, and the a priori threshold for statistical significance was 0.05.) · Estimated intervention effect at 24 mo.: -0.33 · 95% CI -0.57 to -0.09The p-value is for the Wald test (4 DoF) evaluating whether the Greenlight Plus and Greenlight group trajectories were significantly different. The estimation parameter is the model-estimated intervention effect at 24 months (kg/m).
SecondaryChild BMI Z-score Trajectory
Time frame:
Baseline to 24 months

Results for this outcome have not been posted.

SecondaryChild Weight-for-length Z-score Trajectory
Time frame:
Baseline to 24 months

Results for this outcome have not been posted.

SecondaryChild Overweight and/or Obesity

Outcome defined by CDC or WHO standards

Time frame:
at 24 months

Results for this outcome have not been posted.

Adverse events

Collected over Adverse event data were collected across the study's 2-year duration for each participant.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Greenlight Plus0/898 (0%)0/898 (0%)1/898 (0.1%)
Greenlight2/902 (0.2%)0/902 (0%)0/902 (0%)

Baseline characteristics

The number of individual participants in the Greenlight Plus group was n=898 (449 children and 449 parents), and the number of individual participants in the Greenlight group was n=902 (451 children and 451 parents).

Age, Customized
Age, Customized(weeks)Greenlight PlusGreenlightTotal
Child gestational age39.3 (38.6 to 40.0)39.1 (38.4 to 40.0)39.1 (38.4 to 40.0)
Age, Customized
Age, Customized(years)Greenlight PlusGreenlightTotal
Parent age30.2 (25.6 to 34.2)30.1 (25.6 to 34.4)30.1 (25.6 to 34.3)
Sex/Gender, Customized
Sex/Gender, Customized(Participants)Greenlight PlusGreenlightTotal
Sex of child-Female243233476
Sex of child-Male206218424
Sex of parent-Female433441874
Sex of parent-Male151025
Sex of parent-Other101
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)Greenlight PlusGreenlightTotal
Child race/ethnicity — Black, non-Hispanic6281143
Child race/ethnicity — Hispanic204201405
Child race/ethnicity — White, non-Hispanic9590185
Child race/ethnicity — Other or multiple8679165
Parent race/ethnicity — Black, non-Hispanic6885153
Parent race/ethnicity — Hispanic230215445
Parent race/ethnicity — White, non-Hispanic104100204
Parent race/ethnicity — Other or multiple475198
Child birth weight
Child birth weight(kg)Greenlight PlusGreenlightTotal
Median3.3 (3.1 to 3.6)3.3 (3.0 to 3.6)3.3 (3.0 to 3.6)
Parent health literacy
Parent health literacy(Participants)Greenlight PlusGreenlightTotal
Adequate186185371
Limited250250500
Parent preferred language
Parent preferred language(Participants)Greenlight PlusGreenlightTotal
Spanish155158313
English294293587
Parent education level
Parent education level(Participants)Greenlight PlusGreenlightTotal
No school123
Grade school (K-4)549
Middle school (5-8)263965
Some high school (9-12)5860118
High school graduate or GED127101228
Some college or technical/vocational school7681157
College degree90100190
Post graduate or professional degree6664130

2 further baseline measures are reported on the registry.

08

Study locations

6 sites
  • Stanford University
    Stanford, California 94305, United States
  • University of Miami
    Coral Gables, Florida 33146, United States
  • New York University
    New York, New York 10003, United States
  • University of North Carolina
    Chapel Hill, North Carolina 27599, United States
  • Duke University
    Durham, North Carolina 27708, United States
  • Vanderbilt University Medical Center
    Nashville, Tennessee 37203-2494, United States
09

References and documents

Publications

  • Heerman WJ, Perrin EM, Yin HS, Schildcrout JS, Delamater AM, Flower KB, Sanders L, Wood C, Kay MC, Adams LE, Rothman RL. The Greenlight Plus Trial: Comparative effectiveness of a health information technology intervention vs. health communication intervention in primary care offices to prevent childhood obesity. Contemp Clin Trials. 2022 Dec;123:106987. doi: 10.1016/j.cct.2022.106987. Epub 2022 Oct 30. PubMed 36323344 ↗
  • Flower KB, Delamater AM, Wallace S, Yin HS, Schilling S, Heerman WJ, Perrin EM, Schildcrout JS, Rothman RL, Wood C, Kay MC, Sanders L. Exploring Relationships Between Clinic Intervention Dosage and Child Weight Trajectories in the Greenlight Plus Trial. J Pediatr. 2026 Sep 3:115313. doi: 10.1016/j.jpeds.2026.115313. Online ahead of print. PubMed 42692141 ↗
  • Heerman WJ, Rothman RL, Sanders LM, Schildcrout JS, Flower KB, Delamater AM, Kay MC, Wood CT, Gross RS, Bian A, Adams LE, Sommer EC, Yin HS, Perrin EM; Greenlight Investigators; de la Barrera B, Bility M, Cruz Jimenez Smith M, Cruzatte EF, Guevara G, Howard JB, Lampkin J, Orr CJ, Pilotos McBride J, Quintana Forster L, Ramirez KS, Rodriguez J, Schilling S, Shepard WE, Soto A, Velazquez JJ, Wallace S. A Digital Health Behavior Intervention to Prevent Childhood Obesity: The Greenlight Plus Randomized Clinical Trial. JAMA. 2024 Dec 24;332(24):2068-2080. doi: 10.1001/jama.2024.22362. PubMed 39489149 ↗

Study documents

  • Protocol and statistical analysis plan · Jan 4, 2024

Documents are hosted by the registry — open the source record to download them.

10

Updates

1 registry update since Sep 25, 2026
Minor edits
Nothing that changes what the study is or who can join. Edited: references
1 update, last Sep 29, 2026
Show all 1 update
  1. Sep 29, 2026
    Minor edits only
    + 1 other change: references

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT04042467
Lead sponsor
Vanderbilt University Medical Center
Collaborators
Patient-Centered Outcomes Research Institute, Duke University, University of North Carolina, Chapel Hill, Stanford University, NYU Langone Health, University of Miami, Johns Hopkins University
Responsible party
Bill Heerman (Assistant Professor, Internal Medicine and Pediatrics, Vanderbilt University Medical Center) — Principal investigator
First posted
Aug 2, 2019
Start date
Nov 6, 2019
Primary completion
Jan 17, 2024
Completion
Jan 17, 2024
Results posted
Oct 16, 2025
Last update
Sep 29, 2026

Study contacts

Russell Rothman, MD, MPP
principal investigator · Vanderbilt University Medical Center
William Heerman, MD, MPH
principal investigator · Vanderbilt University Medical Center
Charles Wood, MD, MPH
principal investigator · Duke University
Kori Flower, MD, MS, MPH
principal investigator · University of North Carolina, Chapel Hill
Lee Sanders, MD, MPH
principal investigator · Stanford University
H. Shonna Yin, MD, MS
principal investigator · NYU School of Medicine, NYU Langone Health
Alan Delamater, PhD
principal investigator · University of Miami
Eliana Perrin, MD, MPH
principal investigator · Johns Hopkins University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion